Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for restlessness after rhinoplasty
IRCT20200907048652N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin in Emergence agitation (EA) and None, sponsored by Shiraz University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
gabapentin
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20200907048652N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200907048652N2.